 - Determine the safety and toxicity of recombinant carcinoembryonic antigen CEA-expressing measles virus MV-CEA and oncolytic measles virus encoding thyroidal sodium iodide symporter MV-NIS in patients with progressive, recurrent, or refractory ovarian epithelial or primary peritoneal cavity cancer MV-CEA closed as of 06022008. 